Covid-19: Nursing homes to face action by BMC

In a statement issued by BMC that it will issue notices to around 25% of the total 1,496 nursing homes in the city asking them why the nursing homes should not lose their licenses.

The Brihanmumbai Municipal Corporation (BMC) will issue suspension license notices to 428 nursing homes that remained shut despite repeated warnings and advisories from authorities to keep clinics open to treat non-Covid-19 patients.

Last week, Municipal commissioner Praveen Pardeshi had directed the public health department to issue advisories and guidelines to reopen nursing homes and private clinics.

BMC had also warned housing societies to not object to reopening of private clinics in their premises and had also requested private clinics to practise tele-medicine facility, if possible. Thousands of citizens are not getting medical aid and treatment for non-Covid-19 ailments as many private clinics, nursing homes have shut shop.

The authorities has also decided to set up additional 500 beds for quarantine and isolation facilities in Bandra-Kurla Complex (BKC) at MMRDA grounds. The civic body has also set up a 1,200-bedded quarantine facility at Nesco exhibition centre, Goregaon (East). Out of the 1,200 beds, around 1,000 beds will have oxygen support attached to the beds.

  • Related Posts

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid